Characterization of medulloblastoma in Fanconi Anemia: A novel mutation in the BRCA2 gene and SHH molecular subgroup

Evelina Miele, Angela Mastronuzzi, Agnese Po, Andrea Carai, Vincenzo Alfano, Annalisa Serra, Giovanna Stefania Colafati, Luisa Strocchio, Manila Antonelli, Francesca Romana Buttarelli, Massimo Zani, Sergio Ferraro, Amelia Buffone, Alessandra Vacca, Isabella Screpanti, Felice Giangaspero, Giuseppe Giannini, Franco Locatelli, Elisabetta Ferretti

Research output: Contribution to journalArticle

Abstract

Fanconi Anemia (FA) is an inherited disorder characterized by the variable presence of multiple congenital somatic abnormalities, bone marrow failure and cancer susceptibility. Medulloblastoma (MB) has been described only in few cases of FA with biallelic inactivation in the tumor suppressor gene BRCA2/FANCD1 or its associated gene PALB2/FANCN. We report the case of a patient affected by Fanconi Anemia with Wilms tumor and unusual presentation of two medulloblastomas (MB1 and MB2). We identified a new pathogenetic germline BRCA2 mutation: c.2944_2944delA. Molecular analysis of MBs allowed us to define new features of MB in FA. MBs were found to belong to the Sonic Hedgehog (SHH) molecular subgroup with some differences between MB1 and MB2. We highlighted that MB in FA could share molecular aspects and hemispheric localization with sporadic adult SHH-MB. Our report provides new findings that shed new light on the genetic and molecular pathogenesis of MB in FA patients with implications in the disease management.
Original languageEnglish
Pages (from-to)1-13
Number of pages13
JournalBiomarker Research
Volume3
DOIs
Publication statusPublished - 2015

Keywords

  • BRCA2
  • FANCD1
  • SHH molecular subgroup
  • Medulloblastoma
  • Fanconi anemia

Fingerprint

Dive into the research topics of 'Characterization of medulloblastoma in Fanconi Anemia: A novel mutation in the BRCA2 gene and SHH molecular subgroup'. Together they form a unique fingerprint.

Cite this